Back to Trades
Yu John S
CEO and ChairmanDirector10% OwnerCIK 0001550545
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025
Across 1 filing between 2025, Yu John S, CEO and Chairman, Director, 10% Owner, has disclosed $0 in transactions — all concentrated in Kairos Pharma, LTD. (KAPA). Data is sourced from official SEC Form 3, 4, and 5 filings.